LBT Innovations Ltd News

LBT Innovations Sells APAS Independence Instrument to NovaCina

LBT Innovations (ASX:LBT) agreed to the direct sale of APAS Independence, together with the APAS PharmaQC annual software license and maintenance and support services, to development and manufacturing

MT NewswiresApr 28 21:16 ET

Australian Shares Track Gains of Wall Street Peers as Market Shrugs Off US Inflation Data

Australian shares on Wednesday tracked the gains of their Wall Street peers, which rallied despite the stronger-than-expected US inflation data. The S&P/ASX 200 Index rose 16.90 points, or 0.2%, to 7,

MT NewswiresMar 13 01:51 ET

LBT Innovations Confirms APAS PharmaQC Ready for Sale to Global Biopharma Markets

LBT Innovations (ASX: LBT) has announced that its APAS (Automated Plate Assessment System) PharmaQC technology for automated imaging, analysis and interpretation of microbiology culture plates is ready for sale to global markets.

Small CapsMar 12 23:11 ET

LBT Innovations' APAS PharmaQC Completes Primary Validation; Shares Up 79%

Medical technology company LBT Innovations (ASX:LBT) completed primary validation for its APAS PharmaQC product, according to a Wednesday filing with the Australian Securities Exchange. The technology

MT NewswiresMar 12 21:59 ET

Stocks of the Hour: ABx Group, LBT Innovations, NickelSearch

To register for Friday's webinar click here.ABx Group (ASX:ABX) announced high-grade rare-earth elements results from the recently completed 97-hole drilling campaign at Rubble Mound. The results enla

sharecafeMar 12 20:50 ET

LBT Innovations Delivers APAS Hardware, Software to Thermo Fisher

LBT Innovations (ASX:LBT) has delivered an APAS Independence instrument, along with APAS PharmaQC software, to Nasdaq-listed biotechnology firm Thermo Fisher Scientific. That delivery was part of a st

MT NewswiresFeb 23 05:43 ET

LBT Innovations Makes First Sale of APAS PharmaQC; Shares Jump 31%

LBT Innovations (ASX:LBT) delivered an APAS Independence instrument with APAS PharmaQC software to a Thermo Fisher facility, marking the first sale of the product, the medical technology company said

MT NewswiresFeb 21 21:53 ET

Stocks of the Hour: 88 Energy, Auric Mining, LBT Innovations

To register for Friday's webinar click here.88 Energy (ASX:88E, AIM:88E, OTC:EEENF) announced the successful WI Transfer by Monitor Exploration Limited to 88 Energy in relation to Petroleum Exploratio

sharecafeFeb 21 20:10 ET

LBT Innovations Secures Approval for AU$1.7 Million Loan Restructuring

LBT Innovations (ASX:LBT) said it secured approval to restructure the remaining AU$1.7 million loan with the South Australian Government Financing Authority. The approval was for the restructuring of

MT NewswiresNov 6, 2023 02:23 ET

LBT Innovations Fully Repays Share Placement Facility

LBT Innovations (ASX:LBT) repaid in full its share placement facility with fund manager Lind Global Fund II, according to a Friday disclosure. The microbiology automation firm secured AU$1.5 million i

MT NewswiresOct 12, 2023 23:28 ET

LBT Innovations Raising Up to AU$4.5 Million Via Entitlement Offer; Shares Down 27%

LBT Innovations (ASX:LBT) seeks to raise up to AU$4.5 million via a 4-for-1 entitlement offer of 900 million shares at AU$0.005 apiece. Proceeds will be used to accelerate the commercial activation of

MT NewswiresOct 12, 2023 22:45 ET

Stocks of the Hour: LBT Innovations, Selfwealth, Lucapa Diamond Co

LBT Innovations (ASX:LBT) announced a $4.5m partially underwritten renounceable Entitlement Offer on a 4 for 1 basis. In response, LBT Chair, Ms Rebecca Wilson said, "Pleasingly we have secured underw

sharecafeOct 12, 2023 20:50 ET

LBT Innovations Secures R&D Tax Refund for Fiscal Year 2023; Shares Rally 11%

LBT Innovations (ASX:LBT) secured a tax refund worth $848,673 for the fiscal year ended June 30 as part of the Australian government's research and development tax incentive scheme, according to a Tue

MT NewswiresSep 4, 2023 23:43 ET

LBT Innovations Flags AU$13 Million Impairment Charge

LBT Innovations (ASX:LBT) flagged a non-cash impairment charge of AU$13.4 million due to a write-down of the carrying value of the company's intangible assets related to the APAS technology, according

MT NewswiresAug 4, 2023 02:59 ET

LBT Innovations (ASX:LBT) Partners With AstraZeneca for APAS Pharma Development

The Market HeraldJan 8, 2023 22:16 ET

LBT Innovations (ASX:LBT) Appoints Thermo Fisher as European Distributor of APAS Independence

The Market HeraldDec 18, 2022 19:36 ET